BioCardia, Inc.BCDANASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank57
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-0.75
↑ 91% vs avg
Percentile
P57
Within normal range
Streak
2 yr
Consecutive growthElevated
Average
-7.97
Historical baseline
PeriodValueYoY Change
2024-0.75+38.1%
2023-1.22+87.0%
2022-9.33-19.6%
2021-7.80-11.5%
2020-7.00-65.2%
2019-4.24+57.1%
2018-9.88+54.8%
2017-21.86+30.8%
2016-31.57-326.1%
201513.96-